How to buy Tekla Healthcare Investors stock (HQH)

Tekla Healthcare Investors is an asset management business based in the US. Tekla Healthcare Investors shares (HQH) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $18.19 – a decrease of 0.82% over the previous week.

Our top picks for where to buy Tekla Healthcare Investors stock

Buy Tekla Healthcare Investors stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Tekla Healthcare Investors stock price (NYSE: HQH)

Use our graph to track the performance of HQH stocks over time.

Tekla Healthcare Investors shares at a glance

• Key figures

Information last updated 2024-11-01.

Latest market close	$18.19
52-week range	$13.09 - $19.24
50-day moving average more info button	$18.62
200-day moving average more info button	$17.59
Wall St. target price	N/A
PE ratio more info button	13.7634
Dividend yield more info button	$1.66 (11.31%)
Earnings per share (TTM) more info button	$1.31

Is it a good time to buy Tekla Healthcare Investors stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tekla Healthcare Investors price performance over time

Historical closes compared with the close of $18.16 from 2024-11-01

1 week (2024-10-29)	-0.98%
1 month (2024-10-04)	-1.52%
3 months (2024-08-06)	-1.78%
6 months (2024-05-06)	8.81%

1 year (2023-11-06)	16.04%
2 years (2022-11-02)	-2.89%
3 years (2021-11-05)	25.5
5 years (2019-11-06)	9.53%

Is Tekla Healthcare Investors stock undervalued or overvalued?

Valuing Tekla Healthcare Investors stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tekla Healthcare Investors's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Tekla Healthcare Investors's P/E ratio

Tekla Healthcare Investors's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, Tekla Healthcare Investors shares trade at around 14x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Tekla Healthcare Investors financials

Revenue TTM	$10 million
Gross profit TTM	$8.3 million
Return on assets TTM	-0.07%
Return on equity TTM	7.34%
Profit margin	730.94%
Book value	$19.91
Market Capitalization more info button	$919.3 million

TTM: trailing 12 months

Tekla Healthcare Investors's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Tekla Healthcare Investors.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Tekla Healthcare Investors's total ESG risk score

Total ESG risk: 29.97

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Tekla Healthcare Investors's overall score of 29.97 (as at 12/31/2018) is excellent – landing it in it in the 6th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Tekla Healthcare Investors is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Tekla Healthcare Investors's environmental score

Environmental score: 3.07/100

Tekla Healthcare Investors's environmental score of 3.07 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Tekla Healthcare Investors is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Tekla Healthcare Investors's social score

Social score: 17.72/100

Tekla Healthcare Investors's social score of 17.72 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Tekla Healthcare Investors is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Tekla Healthcare Investors's governance score

Governance score: 9.07/100

Tekla Healthcare Investors's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Tekla Healthcare Investors is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Environmental, social, and governance (ESG) summary

Tekla Healthcare Investors was last rated for ESG on: 2019-01-01.

Total ESG score	29.97
Total ESG percentile	6
Environmental score	3.07
Environmental score percentile	6
Social score	17.72
Social score percentile	6
Governance score	9.07
Governance score percentile	6

Tekla Healthcare Investors share dividends

Dividend payout ratio: 126.72% of net profits

Recently Tekla Healthcare Investors has paid out, on average, around 100% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Tekla Healthcare Investors shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Tekla Healthcare Investors's case, that would currently equate to about $1.66 per share.

Tekla Healthcare Investors's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

Tekla Healthcare Investors's most recent dividend payout was on 30 December 2018. The latest dividend was paid out to all shareholders who bought their shares by 22 August 2024 (the "ex-dividend date").

Tekla Healthcare Investors share price volatility

Over the last 12 months, Tekla Healthcare Investors's shares have ranged in value from as little as $13.0903 up to $19.24. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Tekla Healthcare Investors's is 0.736. This would suggest that Tekla Healthcare Investors's shares are less volatile than average (for this exchange).

Tekla Healthcare Investors overview

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Frequently asked questions

What percentage of Tekla Healthcare Investors is owned by insiders or institutions?
Currently 0.007% of Tekla Healthcare Investors shares are held by insiders and 27.772% by institutions. When does the fiscal year end for Tekla Healthcare Investors?
Tekla Healthcare Investors's fiscal year ends in September. Where is Tekla Healthcare Investors based?
Tekla Healthcare Investors's address is: 1900 Market Street, Philadelphia, PA, United States, 19103 What is Tekla Healthcare Investors's ISIN number?
Tekla Healthcare Investors's international securities identification number is: US87911J1034 What is Tekla Healthcare Investors's CUSIP number?
Tekla Healthcare Investors's Committee on Uniform Securities Identification Procedures number is: 404052961